HomeOur ServicesConnect Education WorkshopsTagged: Personalized MedicineHomeOur ServicesConnect Education WorkshopsTagged: Personalized MedicineConnect Education Workshops About Personalized MedicineYou can also browse all resources about personalized medicine»Upcoming WorkshopsThere are no upcoming workshops Past workshops For All CancersWhat’s New in Precision MedicineTags:biomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapypersonalized medicinetargeted treatmentsUnderstanding Diagnostic Technologies and BiomarkersTags:biomarkersdiagnostic testsgenomicspersonalized medicinetargeted treatmentstreatmentFor Bladder CancerBladder Cancer: Treatment UpdatesPart I of Living with Bladder CancerTags:bladder cancerclinical trialsdiagnostic testsimmunotherapypersonalized medicinetargeted treatmentstreatmentFor Breast CancerManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Cutaneous T-Cell LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Diffuse Large B-Cell LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Endometrial CancerProgress in the Treatment of Endometrial CancerTags:endometrial canceruterine cancerpersonalized medicinetargeted treatmentstreatmentFor Follicular LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Gastric CancerAdvances in the Treatment of Gastric CancerTags:gastric cancergastrointestinal stromal tumorsstomach cancerbiomarkerschemotherapyimmunotherapypersonalized medicinetargeted treatmentstreatmentFor Gastrointestinal Stromal TumorsAdvances in the Treatment of Gastric CancerTags:gastric cancergastrointestinal stromal tumorsstomach cancerbiomarkerschemotherapyimmunotherapypersonalized medicinetargeted treatmentstreatmentFor Head and Neck CancerOral, Head and Neck Cancer: Treatment UpdatesTags:head and neck canceradherencechemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatmentFor Hodgkin LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Lung CancerManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Mantle Cell LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Marginal Zone LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor MelanomaUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor MesotheliomaMesothelioma: Innovative Treatment OptionsTags:mesotheliomaadherencebiomarkerschemotherapyclinical trialsimmunotherapypersonalized medicinetargeted treatmentstreatmentFor Metastatic Breast CancerManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Non-Hodgkin LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Peripheral T-Cell LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Small Lymphocytic LymphomaManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Stomach CancerAdvances in the Treatment of Gastric CancerTags:gastric cancergastrointestinal stromal tumorsstomach cancerbiomarkerschemotherapyimmunotherapypersonalized medicinetargeted treatmentstreatmentFor Triple Negative Breast CancerManaging the Side Effects of ImmunotherapyPart II of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicineUnderstanding the Role of Immunotherapy in Treating CancerPart I of New Trends in ImmunotherapyTags:breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatmentsFor Uterine CancerProgress in the Treatment of Endometrial CancerTags:endometrial canceruterine cancerpersonalized medicinetargeted treatmentstreatment